Tolerability and efficacy of classical CMF (cCMF) using oral cyclophosphamide (OC) vs intravenous cyclophosphamise (IVC) in early stage breast cancer: A non-randomised comparison of patients (pts) treated in the National Epirubicin Adjuvant Trial (NEAT) 40th Annual American Society of Slinical Oncology meeting. New Orleans, Louisiana USA June 2004

Research output: Contribution to journalArticle


  • DW Hiller
  • L Earl
  • HM Dunn
  • David Spooner
  • R Grieve
  • RK Agrawal

Colleges, School and Institutes


Original languageEnglish
Pages (from-to)595S
JournalJournal of Clinical Oncology
Volume22 (14)
Publication statusPublished - 1 Jan 2007